Ali Kord Valeshabad1, Masood Naseripour2, Rajab Asghari3, Seyed Hamid Parhizgar4, Seyed Ehsan Parhizgar3, Mohammad Taghvaei5, Shahin Miri3. 1. Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois 60612, USA. 2. Department of Ophthalmology, Eye Research Center, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran 40211, Iran. 3. School of Medicine, Tehran University of Medical Sciences, Tehran 40261, Iran. 4. Department of Ophthalmology, Baqiyatallah University of Medical Sciences, Tehran 41570, Iran. 5. Department of Neurosurgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran 40211, Iran.
Abstract
AIM: To assess main indications, postoperative complications and clinicopathological correlation of ocular enucleation-evisceration. METHODS: A total of 107 subjects who underwent enucleation and/or evisceration and received hydroxyapatite implants (Scleral wrap or mesh) were assessed. For each patient clinicopathological data was collected which included demographic information, clinical history, primary clinical diagnosis, main cause of ophthalmic surgery (traumatic, non-traumatic), type of surgical procedure (enucleation, evisceration) and pathological report. Patients' postoperative clinical visits were checked for procedure-related complications during first year after surgery. RESULTS: ONE HUNDRED AND SEVEN PATIENTS (MALE: 65.4%; mean age: 26y) underwent enucleation (n=100) or evisceration (n=7) due to traumatic (n=41) and non-traumatic (n=66) causes. Disfiguring painful blind eye was the most common indication of surgery (66.4%), followed by leukocoria (19.6%) and endophthalmitis (4.7%). The main types of injury included firecracker, traffic and work accidents, and sharp object perforating injury. In 53 (80.3%) subjects in non-traumatic group the initial clinical diagnosis matched the histopathological results. Malignant tumors (retinoblastoma: 47.5%, malignant melanoma: 27.3%) were the most common pathological diagnoses followed by phthisis bulbi (25.8%). The most common procedure-related complications were major eye discharge (39.6%), and implant exposure and discharge (20.8%). CONCLUSION: Trauma and malignant tumors are the leading causes of enucleation-evisceration. Despite developing new techniques and materials, enucleation is still associated with considerable postoperative complications.
AIM: To assess main indications, postoperative complications and clinicopathological correlation of ocular enucleation-evisceration. METHODS: A total of 107 subjects who underwent enucleation and/or evisceration and received hydroxyapatite implants (Scleral wrap or mesh) were assessed. For each patient clinicopathological data was collected which included demographic information, clinical history, primary clinical diagnosis, main cause of ophthalmic surgery (traumatic, non-traumatic), type of surgical procedure (enucleation, evisceration) and pathological report. Patients' postoperative clinical visits were checked for procedure-related complications during first year after surgery. RESULTS: ONE HUNDRED AND SEVEN PATIENTS (MALE: 65.4%; mean age: 26y) underwent enucleation (n=100) or evisceration (n=7) due to traumatic (n=41) and non-traumatic (n=66) causes. Disfiguring painful blind eye was the most common indication of surgery (66.4%), followed by leukocoria (19.6%) and endophthalmitis (4.7%). The main types of injury included firecracker, traffic and work accidents, and sharp object perforating injury. In 53 (80.3%) subjects in non-traumatic group the initial clinical diagnosis matched the histopathological results. Malignant tumors (retinoblastoma: 47.5%, malignant melanoma: 27.3%) were the most common pathological diagnoses followed by phthisis bulbi (25.8%). The most common procedure-related complications were major eye discharge (39.6%), and implant exposure and discharge (20.8%). CONCLUSION:Trauma and malignant tumors are the leading causes of enucleation-evisceration. Despite developing new techniques and materials, enucleation is still associated with considerable postoperative complications.
Authors: Marie Louise Roed Rasmussen; Jan Ulrik Prause; Martin Johnson; Finn Kamper-Jørgensen; Peter Bjerre Toft Journal: Acta Ophthalmol Date: 2008-12-24 Impact factor: 3.761
Authors: Gábor Tóth; Nóra Szentmáry; Gábor László Sándor; Béla Csákány; Erika Maka; Jeannette Tóth; Zsuzsanna Antus; Milán Tamás Pluzsik; Achim Langenbucher; Zoltán Zsolt Nagy; Olga Lukáts Journal: J Ophthalmol Date: 2019-02-14 Impact factor: 1.909